Related references
Note: Only part of the references are listed.Comparative proteomic profiling of plasma very-low-density and low-density lipoproteins
Hung-Yu Sun et al.
CLINICA CHIMICA ACTA (2010)
Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme
Cristina Banfi et al.
PROTEOMICS (2009)
Phospholipolytic activities associated with electronegative low-density lipoprotein are involved in increased self-aggregation
Cristina Bancells et al.
BIOCHEMISTRY (2008)
Low density lipoprotein misfolding and amyloidogenesis
Tiziana Parasassi et al.
FASEB JOURNAL (2008)
Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr
Marcus Stahlman et al.
JOURNAL OF LIPID RESEARCH (2008)
Pro-apoptotic low-density lipoprotein subfractions in type II diabetes
Chao-Yuh Yang et al.
ATHEROSCLEROSIS (2007)
Pro-inflammatory action of LDL(-) on mononuclear cells is counteracted by increased IL10 production
Sonia Benitez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic
Hsin-hung Chen et al.
JOURNAL OF LIPID RESEARCH (2007)
Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC)
A. K. Chauhan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
An oral ApoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice
M Navab et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Clusterin inhibits apoptosis by interacting with activated Bax
HL Zhang et al.
NATURE CELL BIOLOGY (2005)
A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes
P Davidsson et al.
JOURNAL OF LIPID RESEARCH (2005)
Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
A Chait et al.
JOURNAL OF LIPID RESEARCH (2005)
Lipoproteomics I: Mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry
H Karlsson et al.
PROTEOMICS (2005)
Effect of Simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor
S Benítez et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction
S Benítez et al.
CIRCULATION (2003)
Electronegative LDL of FH subjects:: chemical characterization and induction of chemokine release from human endothelial cells
JL Sánchez-Quesada et al.
ATHEROSCLEROSIS (2003)
Evidence that clusterin has discrete chaperone and ligand binding sites
JN Lakins et al.
BIOCHEMISTRY (2002)
Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes:: Relation to nonenzymatic glycosylation and oxidative modification
JL Sánchez-Quesada et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL-
T Parasassi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Share Paper
